Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie 01. September 2026
Suchen
Gastroplattform
Neoplasie
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Leber
Magen-Darm
Oesophagus
Pankreas
Neoplasie
Pankreatitis
Anderes
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 3068  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 61345  
   
Effectiveness and conversion outcomes of immune checkpoint inhibitors combined with lenvatinib and GEMOX chemotherapy as first-line treatment for advanced gallbladder cancer: A multicenter study.
Chin Med J (Engl)
Li S, Yu G, Feng S, Piao M, Zhou Z, Li C, Xun Z, Sun B, Li J, Zhang N, Sun Y, Zhu Z, Zhao H.
PMID: 42675530 [PubMed - as supplied by publisher]


Transcriptomic Profiling of Adhesion GPCRs in Pancreatic Adenocarcinoma Identifies ADGRG7 and ADGRF1 as Novel Diagnostic Biomarkers and Therapeutic Targets.
Anticancer Res
Khan AA, Cho SG.
PMID: 42674700 [PubMed - indexed for MEDLINE]


Neoadjuvant Gemcitabine Plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score-matched Study.
Anticancer Res
Kishi T, Nakamura K, Tanaka T, Ishitobi K, Kaji S, Taniura T, Matsubara T, Yamamoto T, Hidaka M.
PMID: 42674690 [PubMed - indexed for MEDLINE]


Identification of factors associated with rash during gemcitabine plus nanoparticle albumin-bound paclitaxel treatment for pancreatic cancer.
Support Care Cancer
Saito Y, Takekuma Y, Komatsu Y, Sugawara M.
PMID: 42671618 [PubMed - indexed for MEDLINE]


Integrated pan-cancer analysis reveals a cancer-associated fibroblast oxidative stress response signature predicting immunotherapy response and prognosis.
Apoptosis
Tang J, Lv C, Dong S, Song L, Liu Y, Luo D, Long Y, Xiao D, Tao Y, Liu S.
PMID: 42671485 [PubMed - indexed for MEDLINE]


Cholesterol metabolism dysregulation in eyelid sebaceous gland carcinoma and its clinical significance.
Indian J Ophthalmol
Rafat S, Sen S, Chosdol K, Bakhshi S, Kashyap S, Pushker N.
PMID: 42671098 [PubMed - indexed for MEDLINE]


Thiolated Natural Gum-Based Drug Delivery Techniques and Their Efficiency in Diabetes Mellitus and Associated Carcinoma: Possibilities, Pathways, Applications, and Challenges.
Assay Drug Dev Technol
Shah DZ, Jana BK, Das AK, Gogoi NR, Sarkar T, Singh M, Mazumder B.
PMID: 42670202 [PubMed - as supplied by publisher]


Multi-modal direct LINAC parameter prediction for pancreatic VMAT: An optimization-free approach.
Med Phys
Guan Z, Shimizu Y, Iwai T, Yoshimura M, Mizowaki T, Nakamura M.
PMID: 42670037 [PubMed - indexed for MEDLINE]


Management of dynamic therapeutic opportunity in hepatocellular carcinoma: Preserving liver function and enabling treatment transitions.
Biosci Trends
Huang J, Liao M, Tang W.
PMID: 42669489 [PubMed - as supplied by publisher]


Hepatic arterial infusion chemotherapy-based triplet conversion therapy for hepatocellular carcinoma with portal vein tumor thrombus: Evidence, patient selection, and surgical endpoints.
Biosci Trends
Xia C, He Y, Hong R, Wang W, Li H, Wang L, Shi Z.
PMID: 42669488 [PubMed - as supplied by publisher]


Malignant potential of intraductal papillary mucinous neoplasm (IPMN) of the pancreas: imaging assessment of IPMN-derived cancer and concomitant pancreatic ductal adenocarcinoma.
Jpn J Radiol
Toshima F, Inoue D, Kozaka K, Yoneda N, Komori T, Takamatsu A, Chujo Y, Kobayashi S.
PMID: 42669110 [PubMed - as supplied by publisher]


Preoperative biliary stenting is associated with increased bacterial contamination and postoperative inflammation in pancreatic head resections.
BMC Surg
Al-Madhi S, Perrakis A, Acciuffi S, Al-Qahom F, Dölling M, Jeong S, Lemmer P, Boruta M, Alhomsi MO, Andric M, Meyer F, Croner RS, Rahimli M.
PMID: 42668363 [PubMed - indexed for MEDLINE]


Progress and challenges in expanding access to clinical trials in pancreatic cancer.
Commun Med (Lond)
Thang SS, Croagh D, Ananda S, Metz AJ, Cooray P, Poh AR.
PMID: 42668276 [PubMed]


Curcumin in pancreatic cancer: A comprehensive review of anticancer mechanisms, EMT modulation, and clinical challenges.
Cancer Treat Res Commun
Eftekhari H, Tajik Z, Ghafouri-Fard S.
PMID: 42667846 [PubMed - as supplied by publisher]


Real-World-Feasible Immunohistochemistry of ATRX, DAXX, and Menin Identifies a Subgroup of Non-Functioning Pancreatic Neuroendocrine Tumors with low Recurrence Risk to Guide De-Escalating Surveillance.
Endocr Pathol
Verschuur AVD, Hackeng WM, Jairam J, Eldem B, Westendorp JS, Vriens MR, Valk GD, Pea A, Salvia R, Lawlor RT, Scarpa A, Luchini C, Heaphy CM, Hong SM, Marinoni I, Perren A, Dreijerink KMA, van Dijkum EJMN, Sarasqueta AF, Singhi AD, Elias SG, Brosens LAA.
PMID: 42667492 [PubMed - indexed for MEDLINE]


Precision immunotherapy in metastatic pancreatic cancer: OPTIMIZE-1 biomarker-driven patient stratification for future studies.
Ann Pancreat Cancer
Abdelhakeem A, Babiker HM.
PMID: 42667071 [PubMed]


Clinical Impact of the C-Reactive Protein-Albumin-Lymphocyte Index as a Prognostic Biomarker in Patients With Recurrent Pancreatic Cancer.
In Vivo
Sakamoto T, Urakami K, Uehira K, Yoshida J, Kishino M, Morimoto M, Murakami Y, Miyatani K, Shishido Y, Kihara K, Yamamoto M, Matsunaga T, Fujiwara Y.
PMID: 42665404 [PubMed - indexed for MEDLINE]


Perioperative Nutritional Changes Predict Adjuvant S-1 Dose Intensity in Resectable Pancreatic Cancer.
In Vivo
Suto H, Fujita AN, Sakai H, Muramatsu M, Wakamatsu R, Wakamatsu A, Katsuragawa M, Tanaya M, Hiura K.
PMID: 42665382 [PubMed - indexed for MEDLINE]


Intraductal papillary mucinous neoplasms: a comprehensive analysis combining genetic, immunopathological and clinical management.
Curr Probl Cancer
Izzo G, Tralongo P, Cerreto M, Ricciardi G, Ballato M, Giordano WG, Germanà E, Scarfì R, Ieni A, Zuccalà V, Fiorentino V, Carbone C, Martini M, Giuffrè G.
PMID: 42664645 [PubMed - as supplied by publisher]


Influence of LGALS3 polymorphisms on chemotherapy-induced peripheral neuropathy in patients with metastatic pancreatic cancer treated with gemcitabine and nab-paclitaxel: an exploratory biomarker analysis of the GENESECT study.
Invest New Drugs
Hatori M, Tsuji D, Nagai K, Arafune R, Yokokawa T, Kawakami K, Suzuki W, Shibata N, Sasahira N, Ozaka M, Yamaguchi M, Uchino T, Itoh K.
PMID: 42663920 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 61345    Seite 1 von 3068  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1